CEO of ProPhase Labs Ups Ad Spend in Response to ESPN On-Air Commentator
OTC Pharmaceutical Company Supports Stephen A. Smith’s message; it’s all about education
DOYLESTOWN, Pa., May 28, 2014 /PRNewswire/ — ProPhase Labs, Inc.(NASDAQ: PRPH) today announced their support of ESPN’s First Take host, Stephen A. Smith by directing its ad agency to increase advertising of its products on both ESPN and ESPN2.
In response to Stephen A. Smith’s speech on Friday, May 23rd regarding race, role models and the American Dream, Ted Karkus, ProPhase Labs’ Chairman and CEO, has decided to increase the ad spend in an effort to support the commentators overall, insightful message to America’s youth.
“The speech that Stephen A. Smith gave on Friday was not only a motivating one, but provides guidance for all youth in our country,” says Ted Karkus. “Usually you hear about sponsors ‘pulling the plug’ when a commentator says something inappropriate. In this case, I thought to do the opposite, i.e. increase our ad spend to support a speech that literally brought tears to my eyes. Being a CEO of a nationally recognized brand, I understand the obstacles and the hard work it takes to achieve one’s dreams. While Stephen’s speech primarily targeted underprivileged minorities, it was truly a speech that transcended race. It was a message for the youth of America to work hard, become educated, show respect for others and present yourself appropriately so that success can become a reality as opposed to the one out of a billion possibility of becoming the next Lebron or Jay Z. My wife taped the speech and the first thing I did was replay it for my children. I am proud to be an advertiser on ESPN and ESPN2 and look forward to flourishing my relationship with the network and its personalities.”
ProPhase Labs is an OTC pharmaceutical company based in Doylestown, PA. and has been advertising with ESPN for the past 3 years. For more information on ProPhase Labs and Ted Karkus, please visit ProPhaseLabs.com.
About ProPhase Labs
ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE(®) Cold Remedy brand as well as other cold relief products. Cold-EEZE(®) Cold Remedy zinc gluconate lozenges are clinically proven to significantly reduce the duration of the common cold. Cold-EEZE(®) Cold Remedy customers include leading national chain, regional, specialty and local retail stores. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE(®) Cold Remedy lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories, LLC (“Phusion”). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase’s robust over-the-counter distribution channels. For more information visit us at www.ProPhaseLabs.com.
SOURCE ProPhase Labs, Inc.